Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Rogier M. Reijmers et al.|Journal of Clinical Investigation|2019Cited by 232
Multimodal Mass Spectrometry Imaging of <i>N</i>-Glycans and Proteins from the Same Tissue SectionBram Heijs, Liam A. McDonnell, Stephanie Holst et al.|Analytical Chemistry|2016Cited by 109
Hotspot DNA Methyltransferase 3A (DNMT3A) and Isocitrate Dehydrogenase 1 and 2 (IDH1/2) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for ImmunotherapyNadine E. Struckman, Marieke Griffioen, Rob C. M. de Jong et al.|Biomedicines|2024Cited by 6
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E. Struckman, Marieke Griffioen, Georgia Koutsoumpli et al.|Leukemia|2025Cited by 3
Mutated NPM1 As Target for Immunotherapy of Acute Myeloid LeukemiaDyantha I. van der Lee, Marieke Griffioen, Helena M. Bijen et al.|Blood|2017Cited by 2